Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terry D Heiman-Patterson

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|January 19, 2011
Effect of genetic background on phenotype variability in transgenic mouse models of amyotrophic lateral sclerosis: a window of opportunity in the search for genetic modifiersTerry D Heiman-Patterson, Roger B Sher, Elizabeth A Blankenhorn, et al.
Plos One|September 15, 2022
Identification of quantitative trait loci for survival in the mutant dynactin p150Glued mouse model of motor neuron diseaseGuillermo M Alexander, Terry D Heiman-Patterson, Frank Bearoff, et al.
Plos One|March 13, 2015
Genetic background effects on disease onset and lifespan of the mutant dynactin p150Glued mouse model of motor neuron diseaseTerry D Heiman-Patterson, Elizabeth P Blankenhorn, Roger B Sher, et al.
Neurogenetics|September 7, 2014
Mutation in the novel nuclear-encoded mitochondrial protein CHCHD10 in a family with autosomal dominant mitochondrial myopathySenda Ajroud-Driss, Faisal Fecto, Kaouther Ajroud, et al.
Journal of Clinical Neuromuscular Disease|February 25, 2016
Primary Lateral Sclerosis and Early Upper Motor Neuron Disease: Characteristics of a Cross-Sectional PopulationChristina N Fournier, Alyssa Murphy, Lorena Loci, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 18, 2018
Understanding the use of NIV in ALS: results of an international ALS specialist surveyTerry D Heiman-Patterson, Merit E Cudkowicz, Mamede De Carvalho, et al.
Human Molecular Genetics|December 7, 2018
Hereditary spastic paraplegia: gain-of-function mechanisms revealed by new transgenic mouseLiang Qiang, Emanuela Piermarini, Hemalatha Muralidharan, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 21, 2024
Guidance for clinical management of pathogenic variant carriers at elevated genetic risk for ALS/FTDMichael Benatar, Terry D Heiman-Patterson, Johnathan Cooper-Knock, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 16, 2022
Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trialSabrina Paganoni, Suzanne Hendrix, Samuel P Dickson, et al.
Muscle & Nerve|October 16, 2020
Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosisSabrina Paganoni, Suzanne Hendrix, Samuel P Dickson, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|January 19, 2011
Effect of genetic background on phenotype variability in transgenic mouse models of amyotrophic lateral sclerosis: a window of opportunity in the search for genetic modifiersTerry D Heiman-Patterson, Roger B Sher, Elizabeth A Blankenhorn, et al.
Plos One|September 15, 2022
Identification of quantitative trait loci for survival in the mutant dynactin p150Glued mouse model of motor neuron diseaseGuillermo M Alexander, Terry D Heiman-Patterson, Frank Bearoff, et al.
Plos One|March 13, 2015
Genetic background effects on disease onset and lifespan of the mutant dynactin p150Glued mouse model of motor neuron diseaseTerry D Heiman-Patterson, Elizabeth P Blankenhorn, Roger B Sher, et al.
Neurogenetics|September 7, 2014
Mutation in the novel nuclear-encoded mitochondrial protein CHCHD10 in a family with autosomal dominant mitochondrial myopathySenda Ajroud-Driss, Faisal Fecto, Kaouther Ajroud, et al.
Journal of Clinical Neuromuscular Disease|February 25, 2016
Primary Lateral Sclerosis and Early Upper Motor Neuron Disease: Characteristics of a Cross-Sectional PopulationChristina N Fournier, Alyssa Murphy, Lorena Loci, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 18, 2018
Understanding the use of NIV in ALS: results of an international ALS specialist surveyTerry D Heiman-Patterson, Merit E Cudkowicz, Mamede De Carvalho, et al.
Human Molecular Genetics|December 7, 2018
Hereditary spastic paraplegia: gain-of-function mechanisms revealed by new transgenic mouseLiang Qiang, Emanuela Piermarini, Hemalatha Muralidharan, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 21, 2024
Guidance for clinical management of pathogenic variant carriers at elevated genetic risk for ALS/FTDMichael Benatar, Terry D Heiman-Patterson, Johnathan Cooper-Knock, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 16, 2022
Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trialSabrina Paganoni, Suzanne Hendrix, Samuel P Dickson, et al.
Muscle & Nerve|October 16, 2020
Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosisSabrina Paganoni, Suzanne Hendrix, Samuel P Dickson, et al.
Pageof 3